Health System

Panel Reviews Health Inequities and Opportunities for Innovation Through Population Health Delivery

September 30th 2022, 7:05pm


A panel discussion at the 70th Annual Roy A. Bowers Pharmaceutical Conference addressed recent care delivery initiatives in New Jersey that aim to address health inequities and other population health concerns.

Dr Melissa O'Connor Reviews Considerations for Discharge in Home Health

September 30th 2022, 5:10pm


Melissa O'Connor, PhD, MBA, RN, FGSA, FAAN, endowed professor in Community and Home Health Nursing, M. Louise Fitzpatrick School of Nursing, Villanova University, and director, Gerontology Interest Group, discussed several factors for clinicians to consider in creating plans to discharge adults from skilled home health care.

CDC to Physicians: Watch for Severe Respiratory, Polio-Like Illness in Children

September 28th 2022, 9:45pm


The CDC this week noted what providers and parents have been seeing across the country: rising cases of a non-polio enterovirus causing severe respiratory illness and acute flaccid myelitis (AFM).

FAIR Health Releases Report on Substance Use Disorders, Overdoses Before, During Pandemic

September 27th 2022, 8:42pm


One of the key findings of the report is that 42 states saw an increase in the proportion of patients with opioid and opioid-like drug overdoses compared with the total number of patients using medical services by state.

Clostridioides difficile Infection Risk Greater Among Patients Requiring Maintenance Hemodialysis

September 27th 2022, 4:39pm


Patients requiring maintenance hemodialysis (MHD) had a 4-fold higher risk of Clostridioides difficile infection (CDI), with rates of CDI increasing over time regardless of MHD requirement.

AMA’s Dr James Madara to Discuss Precompetitive Positions and Innovation Needs at AAO

September 26th 2022, 7:45pm


During the Parker Health Lecture at the American Academy of Ophthalmology (AAO) annual meeting, James Madara, MD, CEO of the American Medical Association (AMA), will discuss the 3 arcs of the AMA’s strategic framework and the innovation that needs to occur.

Skin Biomarkers Found to Predict Development of Pediatric Atopic Dermatitis

September 26th 2022, 6:07pm


Significant alterations were observed in lipid levels and other skin biomarkers for infants who developed atopic dermatitis (AD) vs controls, with phytosphingosine associated with the highest AD prediction accuracy.

Study Supports Comprehensive Genomic Profiling for Patients With Biliary Tract Cancer

September 24th 2022, 5:00pm


A small study suggests that comprehensive genomic profiling can help with clinical decision-making and predicting clinical outcomes in advanced biliary tract cancer, but further research is needed.

Examining Biologic-Related Adverse Events in CRS With Nasal Polyps

September 23rd 2022, 6:10pm


Headaches, injection site reactions, and pharyngitis were the most common adverse events associated with the biologic therapies dupilumab, omalizumab, mepolizumab, and reslizumab in the treatment of chronic rhinosinusitis (CRS) with nasal polyps.

What We’re Reading: Deal Reached for FDA User Fee Programs; Link Between COVID-19, T1D; DOJ Protects VA Employees Providing Abortions

September 23rd 2022, 2:39pm


A deal was reached to renew 5-year FDA user fee programs; children and adolescents with COVID-19 had a 60% increased risk of developing type 1 diabetes (T1D); states cannot penalize Department of Veterans Affairs (VA) employees for facilitating abortions permitted by federal law.